Amsterdam UMC at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Amsterdam UMC takes part in 7 sessions at ESMO 2026 in Madrid. Its program centres on gastroesophageal cancer, from resectable disease to care for older and comorbid patients, and on bladder preservation in high-risk non-muscle-invasive bladder cancer. Other sessions cover local therapies for oligometastatic colorectal cancer, urothelial cancer after complete response and non-small cell lung cancer.

OrganizationESMO 2026 Attendance
Amsterdam UMC
Amsterdam, Netherlands
Cancer centre & hospital
University medical centre of the University of Amsterdam and Vrije Universiteit Amsterdam, in Amsterdam, Netherlands.
Satellite
Fri Oct 23
18:15–18:20
Welcome and introductions
Johnson & Johnson - Personalizing GU Oncology Treatments: Maximizing Outcomes, Preserving Quality of Life · with Hospital Clínic de Barcelona
Genitourinary cancers
Satellite
Fri Oct 23
19:00–19:40
A new eye on earlier stages in bladder cancer: Redefining bladder preservation in HR NMIBC
Johnson & Johnson - Personalizing GU Oncology Treatments: Maximizing Outcomes, Preserving Quality of Life · with San Raffaele Hospital, Hospital Universitario 12 de Octubre
Genitourinary cancers
Chair
Sat Oct 24
08:30–10:00
Optimising personalised care for gastroesophageal cancer
with Oxford University Hospitals NHS Foundation Trust
Gastrointestinal cancers
Talk
Sat Oct 24
09:30–09:50
Optimising treatment for elderly and comorbid patients
Optimising personalised care for gastroesophageal cancer
Gastrointestinal cancers
Chair
Sun Oct 25
10:15–11:45
Proffered paper 1: NSCLC, metastatic
Lung & thoracic cancers
Talk
Sun Oct 25
17:00–17:15
Is consolidative treatment needed in case of a clinical complete response?
Peri-operative management of urothelial cancer
Genitourinary cancers
Satellite
Mon Oct 26
13:00–14:30
Satellite
Mon Oct 26
13:00–13:05
Welcome and introductions
AstraZeneca - Advancing clinical practice and patient care in gastroesophageal cancer
Gastrointestinal cancers
Satellite
Mon Oct 26
13:05–13:25
Plenary: The emerging standard: optimising clinical practice for resectable GC / GEJC
AstraZeneca - Advancing clinical practice and patient care in gastroesophageal cancer · with Geneva University Hospitals (HUG)
Gastrointestinal cancers
Satellite
Mon Oct 26
13:25–13:30
Audience Q&A
AstraZeneca - Advancing clinical practice and patient care in gastroesophageal cancer · with Geneva University Hospitals (HUG)
Gastrointestinal cancers
Satellite
Mon Oct 26
13:50–14:20
Case study discussion: Current debates and developing paradigms in resectable and advanced GC / GEJC care
AstraZeneca - Advancing clinical practice and patient care in gastroesophageal cancer · with National Cancer Center Hospital East, Hospital del Mar, Geneva University Hospitals (HUG)
Gastrointestinal cancers
Satellite
Mon Oct 26
14:20–14:25
Audience Q&A
AstraZeneca - Advancing clinical practice and patient care in gastroesophageal cancer · with National Cancer Center Hospital East, Hospital del Mar, Geneva University Hospitals (HUG)
Gastrointestinal cancers
Satellite
Mon Oct 26
14:25–14:30
Close
AstraZeneca - Advancing clinical practice and patient care in gastroesophageal cancer
Gastrointestinal cancers
Talk
Mon Oct 26
15:10–15:35
Pushing boundaries with local therapies: Maximizing patient outcomes and recognizing limitations
Optimising outcomes in oligometastatic colorectal cancer: Redefining treatment strategies and future directions
Gastrointestinal cancers
Chair
Mon Oct 26
16:30–18:00
Resectable early stage NSCLC
with University Hospital Zurich
Lung & thoracic cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Amsterdam UMC

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction